The mammary glands of 30 non-pregnant, intact ewes were developed by subcutaneously injecting oestrogen plus progesterone at intervals of 3 days from day 0 to day 27. Two days later (day 29), 15 ewes were injected subcutaneously with 18 mg ergocryptine, to inhibit specifically secretion of prolactin. Then groups of ewes, each comprising five ergocryptine-tre ated and five untreated ewes, were injected from days 30 to 34 with either four intravenous injections each day of 1 i.u. syntocinon, one subcutaneous injection each day of 10 mg dexamethasone trimethylacetate, or two subcutaneous injections each day of 2· 5 mg oestradiol benzoate plus 6·25 mg progesterone. All ewes were milked by hand on days 30-50. Within 24 h of injecting ergocryptine, levels of prolactin in serum were reduced to negligible values ( < 2 ng/ml).
Introduction
Results of recent experiments at this laboratory have shown that copious milk secretion may be initiated in non-pregnant ewes with developed mammary glands by administering daily injections for 6 days of either oestrogen plus progesterone, glucocorticoid or oxytocin McDowell 1974, 1975) . Yields and composition of mammary secretion obtained from such ewes resemble those from ewes lactating after normal pregnancy (Fulkerson and McDowell 1974) . Thus it seems that the non-pregnant ewe which has been induced to lactate artificially may be a useful experimental model for defining the mechanisms of induction of lactation.
The complex of hormones necessary for triggering lactogenesis is known to vary for different species but generally it is considered that prolactin is an important component of this complex (Denamur 1971) . In the present studies an attempt has been made to determine the importance of prolactin for artificial induction of lactation in non-pregnant ewes with developed mammary glands. The experimental model systems outlined above have been used and the ergot alkaloid, ergocryptine, has been used to inhibit specifically the synthesis and release of prolactin from the anterior pituitary (Floss et al. 1973 ).
Materials and Methods

Animals
Thirty nulliparous crossbred (Border Leicester x Merino) ewes were housed in a shed lit by natural light and fed ad libitum a ration containing 90% lucerne chaff and 10% concentrate pellets. When the experiment commenced all ewes were in anoestrus and ewes from the same flock remained in anoestrus for the duration of the experiment.
Hormones and Drugs
Progesterone (Calbiochem, La Jolla, California) and oestradiol benzoate (Schering AG, Berlin) were dissolved in ethanol and administered either in ethanol or in peanut oi!. Oxytocin (Syntocinon, Sandoz Ltd, Basle) was diluted in sterile saline (0' 9 % w Iv) to give a solution containing O· 5 i.u./m!. The synthetic glucocorticoid, dexamethasone trimethylacetate (Opticortenol O· 5 %), was obtained from Ciba Pty Ltd, Lane Cove, Sydney. Ergocryptine (Sigma, St Louis) was dissolved in ethanol then 0'9% (w/v) saline was added to give a solution containing saline and ethanol in the ratio 60: 40 (v/v).
Experimental Procedure
The mammary glands of each ewe were developed by giving a series of 10 subcutaneous injections, 3 days apart, of 240 flg oestradiol benzoate plus 60 mg progesterone in 2· 0 ml of peanut oil. The first of these injections was given on day 0 and the last on day 27. Ewes were then randomly allocated to six groups of five animals and given further treatment as follows:
Group 1: intravenous injection of 1 i.u. syntocinon four times each day at 0800, 1200, 1600 and 2000 h on days 30-34; Group 2: subcutaneous injection of 18 mg ergocryptine at 0800 h on day 29 then syntocinon as for group 1; Group 3: subcutaneous injection of 10 mg dexamethasone trimethylacetate at 0800 h each day on days 30-34; Group 4: subcutaneous injection of 18 mg ergocryptine at 0800 h on day 29 then dexamethasone trimethylacetate as for group 3; Group 5: subcutaneous injection of 2· 5 mg oestradiol benzoate plus 6· 25 mg progesterone each day at 0800 and 2000 h on days 30-34; Group 6: subcutaneous injection of 18 mg ergocryptine at 0800 h on day 29 then oestradiol benzoate plus progesterone as for group 5. The dose of ergocryptine given to ewes in groups 2, 4 and 6 was equivalent to c. O· 5 mg/kg body weight.
All ewes were milked by hand once each day at c. 0800 h on days 30-35 then twice each day at c. 0800 hand 1700 h until the experiment terminated on day 50. Milk yields were recorded at intervals after milking commenced on day 30 and samples of mammary secretion were kept for analysis of lactose. Blood samples were obtained at intervals throughout the experimental period. Milk and blood serum were stored at -16°C pending analyses.
Chemical Analyses
The glucose oxidase method of Huggett and Nixon (1957) was used for the determination of lactose and glucose in mammary secretion. Glucose was determined before and lactose after acid hydrolysis of deproteinized samples of mammary secretion (Cowie et al. 1969) . Glucose levels were negligible in all cases.
Prolactin Assay
Prolactin was assayed by solid-phase radioimmunoass ay according to the method described by Fell et al. (1972) . Levels of prolactin were expressed in terms of the NIH-P-S6 standard.
Results
Development of Mammary Glands
During the period from day 0 to day 27 mammary glands of all ewes increased in size appreciably as assessed visually. By day 27, glands resembled those of ewes 1-2 weeks before parturition. Substantial increases in udder size were observed between days 30 and 34 for ewes not receiving ergocryptine (groups 1, 3 and 5) and by day 40 glands of these ewes were similar in appearance to glands of normal lactating ewes. The udders of ewes in groups 2 and 4 increased in size between days 30 and 34 but to a lesser extent than for ewes receiving no ergocryptine. Glands of ewes in group 6 did not increase in size after day 27 and appeared to regress after day 29 when ergocryptine was injected. 
Milk Production
Mean daily yields of milk for the six groups of ewes are shown in Fig. 1 . Yields from ewes not receiving ergocryptine (groups 1, 3 and 5) were not significantly different except on days 36-40 (6-10 days after milking commenced) when ewes in group 5 produced significantly less (P < 0·05) milk than ewes in groups 1 and 3.
Peak yields of 0·23-0·27 kg/day were recorded between days 45 and 50 (15-20 days after milking commenced) for ewes in groups 1, 3 and 5.
Milk yields of ewes injected with ergocryptine (groups 2, 4 and 6) were significantly less (P < 0·05) than those of ewes not treated with ergocryptine. Ewes in groups 2 (ergocryptine then syntocinon) and 4 (ergocryptine then dexamethasone) produced similar amounts of milk. Peak yields for these ewes of 0·12-0·13 kg/day were recorded between days 45 and 50. Only one of the five ewes in group 6 (ergocryptine then oestrogen plus progesterone) produced measurable quantities (> 3 ml) of secretion during the experiment.
Secretion of ewes in groups 1-5 resembled normal ovine milk in appearance by 3-4 days after milking commenced. Prior to that time, secretion resembled ovine colostrum.
Lactose in Milk
The concentrations of lactose in milk from the six groups of ewes are shown in Fig. 1 . Concentrations oflactose in milk from ewes in groups 1-5 were not significantly different and were similar to concentrations oflactose in normal ovine milk. Although samples were obtained from only one ewe in group 6 throughout the period of milking, the concentration of lactose in secretion from this ewe was similar to that for ewes in groups 1-5.
Prolactin in Serum
Prior to day 29 (when ergocryptine was injected) concentrations of prolactin in serum from ewes in groups 1-4 were high (250-400 ng/ml). On the other hand, concentrations of prolactin in serum of ewes in groups 5 and 6 (20-55 ng/ml) were low (Fig. 1) .
Following injection of ewes in groups 2, 4 and 6 with ergocryptine, concentrations of prolactin in serum from these ewes were reduced to negligible values ( < 2 ng/ml).
Concentrations of prolactin from these ergocryptine-treated ewes remained at extremely low levels after day 30. In contrast, concentrations of prolactin in serum from ewes in groups 1, 3 and 5 (those ewes not treated with ergocryptine) were 30-200 ng/ml throughout the milking period (see Fig. 1 ).
Discussion
The results for ewes in groups 1, 3 and 5 confirm the findings of earlier studies in which it was shown that injections of either syntocinon, dexamethasone or oestradiol benzoate plus progesterone induce essentially normal lactation in non-pregnant intact ewes with developed mammary glands McDowell 1974, 1975) . Direct comparison between the three hormone triggers is possible in the present studies and it is clear that they are equally effective in initiating milk secretion.
Milk yields for ewes in groups 1, 3 and 5 were only about half those reported for ewes in earlier studies (Fulkerson and McDowell 1975) . However, in the present work mammary glands were developed over 30 days (not 60 days as previously) and results of recent studies (Fulkerson, Gow and Darton, unpublished data) suggest that milk yields would have been higher had glands been developed for longer (see also Sud et al. 1968) . Moreover, the strain of sheep used in the present studies has been found to be relatively low-yielding even when lactating after normal pregnancy (Fulkerson, unpublished data) .
In previous studies with cows (Karget al. 1972; Schams et al. 1972; Fell et al. 1974 ) repeated dosage with 2-bromo-oc-ergocryptine has been used to inhibit secretion of prolactin. It is apparent from the present studies that the inhibitory effect on prolactin secretion of a single injection of ergocryptine persists for at least 16 days in the ewe.
Interpretation of the results of the present studies is confounded by the finding that concentrations of prolactin in serum prior to day 29 were high for ewes in groups 1-4 and low for ewes in groups 5 and 6. Confirmation of values was obtained when the assays were repeated, thus. no explanation can be offered to account for the differences observed. It was expected that concentrations of prolactin in serum from all ewes would have been similar and results of subsequent experiments (Fulkerson and Hooley, unpublished data) have shown that concentrations of prolactin in serum are low when non-pregnant ewes are injected with oestradiol benzoate plus progesterone to develop mammary glands.
Results for ewes jn groups 1-4 raise the possibility that syntocinon and dexamethasone are either lactogenic per se or effect release of lactogenic hormones other than prolactin. However, it is possible that the reqUirements for prolactin had been met prior to injecting ewes in groups 2 and 4 with ergocryptine. Certainly, prior to injection of ergocryptine, concentrations of prolactin were as high as those found immediately before parturition in the ewe (Chamley et al. 1973) . In spite of this, injections of ergocryptine severely inhibited (by some 50 %),but did not abolish, the response to injections of syntocinon and dexamethasone.
On the other hand, ergocryptine abolished the lactogenic response to oestradiol benzoate plus progesterone in group 6 ewes. This finding suggests that oestradiol benzoate plus progesterone triggers lactation by influencing release of prolactin. Indeed, it has been shown that injections of oestradiol benzoate lead to substantial rises in the concentrations of prolactin in blood in the sheep (Fell et al. 1972) .
Studies with parturient cattle have shown that prolactin is an important, but not the sole, component of the lactogenic complex. Schams et al. (1972) recorded substantial depressions in milk yield (49-95 % relative to previous lactations) in pregnant cows injected with 2-bromo-ot:-ergocryptine prior to the time when concentrations of prolactin in blood rise (Ingalls et al. 1973; Karg and Schams 1974) . In other studies by Fell et al. (1974) , depressions of only 25 % in milk yield were recorded when parturient cows were injected after prolactin levels began to rise~ Thus the results of the present experiments are consistent with results obtained using normal pregnant animals.
In view of the findings of the present experiments it seems reasonable to propose that syntocinon and dexamethasone are either lactogenic per se or influence release of hormones of the lactogenic complex other than prolactin. In contrast, oestradiol benzoate plus progesterone seems more likely to be lactogenic by virtue of the influence of oestrogen on the release of prolactin. Clearly these interpretations are consistent with the view that, in the late pregnant animal, a complex of hormones is responsible for the onset of copious milk secretion (Cowie and Tindal 1971) .
